Take­da rests its R&D foot­print on U.S. hubs 

Back in late 2014, when Take­da an­nounced that it had re­cruit­ed Sanofi vet An­drew Plump as head of its R&D group, savvy ob­servers were care­ful to note that Plump would be based in the Japan­ese com­pa­ny’s Boston hub. A few days ago, the Japan­ese phar­ma com­pa­ny un­veiled its $725 mil­lion plan to re­or­ga­nize R&D, pulling out of Cam­bridge, UK while con­cen­trat­ing much of the work in the Boston area. This chart from Take­da helps il­lus­trate what’s go­ing on in R&D, as the phar­ma com­pa­ny looks to ex­pand on its links in the key hub while keep­ing San Diego in play for in­dus­try con­nec­tions on the West Coast. Clear­ly, much of its fu­ture col­lab­o­ra­tive work will be done in the U.S. as CEO Christophe We­ber me­thod­i­cal­ly moves to change the cul­ture at Take­da.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER